Colossal Biosciences Resurrects Dire Wolf, Sparks Global Debate

Colossal Biosciences has announced the successful creation of three dire wolf puppies, marking a significant milestone in the company's de-extinction efforts. This achievement has contributed to the company's valuation of $10.2 billion, placing it in the 'decacorn' category. The dire wolves, named Romulus, Remus, and Khaleesi, were engineered using DNA from ancient fossils, although experts have raised concerns about their true genetic lineage and the feasibility of their release into the wild. Critics argue that despite the phenotypic similarities, the puppies do not represent true dire wolves, with some comparing the endeavor to 'Jurassic Park.' Colossal's CEO, Ben Lamm, contends that their work will also have broader applications in health care and conservation. The announcement has sparked a mix of excitement and skepticism within the scientific community, highlighting the complexities of genetic engineering.